Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Measuring Blood Pressure in Pregnancy Using Mercury and Automated Device (PRAM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00809666
Recruitment Status : Completed
First Posted : December 17, 2008
Last Update Posted : December 17, 2008
Information provided by:
St George Hospital, Australia

Brief Summary:
The aim of the PRAM study was to determine whether women diagnosed with hypertension in pregnancy, using the traditional mercury device, have the same pregnancy outcomes when blood pressure is measured by either an automated device or a mercury device throughout the pregnancy.

Condition or disease Intervention/treatment Phase
Hypertension Pregnancy Pre Eclampsia Device: Automated blood pressure recording device Omron HEM 705CP Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 220 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Diagnostic
Official Title: A Prospective Randomised Study of Automated Versus Mercury Blood Pressure Recordings in Pregnancy
Study Start Date : May 2000
Actual Primary Completion Date : September 2006
Actual Study Completion Date : September 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Mercury Pregnancy

Arm Intervention/treatment
No Intervention: Mercury
All subsequent blood pressure recording done using mercury sphygmomanometry
Device: Automated blood pressure recording device Omron HEM 705CP
All subsequent blood pressure recordings done using the automated device

Primary Outcome Measures :
  1. The primary maternal outcome measure was the number of women having any episode of severe hypertension (BP ³ 170/110mmHg).

Secondary Outcome Measures :
  1. Secondary end points included gestation at birth, caesarean section and induction of labour rates.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   16 Years to 45 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • women with a diagnosis of hypertension in pregnancy

Exclusion Criteria:

  • non-pregnant and normotensive pregnancy women

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00809666

Layout table for location information
Australia, New South Wales
St George Hospital
Sydney, New South Wales, Australia, 2217
Sponsors and Collaborators
St George Hospital, Australia
High blood pressure research Council of Australia. Position Statement on the replacement of mercury sphygmomanometers. September 2006.

Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Professor Mark Brown, St George Hospital and UNSW Identifier: NCT00809666    
Other Study ID Numbers: 00/41 Brown
First Posted: December 17, 2008    Key Record Dates
Last Update Posted: December 17, 2008
Last Verified: December 2008
Keywords provided by St George Hospital, Australia:
mercury sphygmomanometry
blood pressure
automated blood pressure
pre eclampsia
Hypertension in pregnancy
Additional relevant MeSH terms:
Layout table for MeSH terms
Vascular Diseases
Cardiovascular Diseases
Hypertension, Pregnancy-Induced
Pregnancy Complications